keyword
MENU ▼
Read by QxMD icon Read
search

gastrointestinal disorders in post renal transplant patients

keyword
https://www.readbyqxmd.com/read/29622763/esophageal-mucosal-calcinosis-a-rare-site-of-gastrointestinal-mucosal-calcinosis
#1
Aaron R Huber, Brandon S Sprung, John Miller, Jennifer J Findeis-Hosey
BACKGROUND Gastrointestinal tract mucosal calcinosis (MC) tends to affect the gastric mucosa, while esophageal involvement is rare. Gastric MC may be seen with solid organ transplantation, use of aluminum-containing antacids or sucralfate, malignancy, and chronic renal failure. While the incidence of gastric MC in renal transplant patients undergoing gastric biopsy is common (between 15-29%), to our knowledge esophageal MC has only been previously reported 3 times. CASE REPORT A 68-year-old male dialysis-dependent end stage renal disease status-post deceased donor kidney transplant underwent an esophagogastroduodenoscopy (EGD) for dysphagia and diffuse esophageal wall thickening seen on imaging studies...
April 6, 2018: American Journal of Case Reports
https://www.readbyqxmd.com/read/29236209/adverse-events-under-tacrolimus-and-cyclosporine-in-the-first-3-years-post-renal-transplantation-in-children
#2
Pauline Lancia, Beate Aurich, Phuong Ha, Anne Maisin, Véronique Baudouin, Evelyne Jacqz-Aigrain
BACKGROUND: Progress in immunosuppression has reduced acute rejection, graft loss and mortality after renal transplantation. Adverse drug reactions are well described in adults but few data are available in children. Our objectives were to analyse the adverse events reported in the first 3 years post-transplantation in children receiving tacrolimus or cyclosporine-based immunosuppression and compare them with the information of the Summary of Product Characteristics. METHODS: This retrospective study included all children who underwent a renal transplant at Hospital Robert Debré between 2002 and 2015...
February 2018: Clinical Drug Investigation
https://www.readbyqxmd.com/read/29179699/gastrointestinal-tuberculosis-following-renal-transplantation-accompanied-with-septic-shock-and-acute-respiratory-distress-syndrome-a-survival-case-presentation
#3
Andrea Cikova, Diana Vavrincova-Yaghi, Peter Vavrinec, Anna Dobisova, Andrea Gebhardtova, Zora Flassikova, Mark A Seelen, Robert H Henning, Aktham Yaghi
BACKGROUND: Post-transplant tuberculosis (PTTB) is a serious opportunistic infection in renal graft recipients with a 30-70 fold higher incidence compared to the general population. PTTB occurs most frequently within the first years after transplantation, manifesting as pulmonary or disseminated TB. Gastrointestinal TB (GITB) is a rare and potentially lethal manifestation of PTTB and may show delayed onset in renal transplant recipients due to the use of lower doses of immunosuppressants...
November 28, 2017: BMC Gastroenterology
https://www.readbyqxmd.com/read/26477696/cysteamine-in-renal-transplantation-a-report-of-two-patients-with-nephropathic-cystinosis-and-the-successful-re-initiation-of-cysteamine-therapy-during-the-immediate-post-transplant-period
#4
Allison Berryhill, Suvarna Bhamre, Abanti Chaudhuri, Waldo Concepcion, Paul C Grimm
Nephropathic cystinosis is a rare disorder causing the accumulation of intracellular cystine crystals in tissues. The damage to the proximal tubules of the kidneys results in Fanconi syndrome, and patients with cystinosis experience the progression of chronic kidney disease, resulting in the need for kidney transplantation. Treatment of cystinosis with cysteamine has proven to be effective; however, it has many gastrointestinal side effects that are concerning for transplant specialists during the immediate post-transplant period...
February 2016: Pediatric Transplantation
https://www.readbyqxmd.com/read/25146844/influence-of-post-transplant-immunosuppressive-therapy-on-gastrointestinal-transit-using-biomagnetic-method-a-pilot-study
#5
Maria do Carmo B Teixeira, Madileine F Américo, Ricardo B Oliveira, José Ricardo A Miranda, Fernando G Romeiro, Luciana A Corá
BACKGROUND: Immunosuppressive therapy after kidney transplant is necessary to prevent allograft rejection and it is the cause of several gastrointestinal (GI) disorders that have been scantily studied. OBJECTIVES: This study was aimed at investigating the influence of triple immunosuppressive therapy on GI transit in renal transplant patients by employing a biomagnetic technique. METHODS: Twenty-one renal transplant patients underwent triple therapy, which included either tacrolimus (TAC) or cyclosporin A (CsA) associated with prednisone and azathioprine...
January 2015: Digestive Diseases and Sciences
https://www.readbyqxmd.com/read/22573235/light-chain-deposition-disease-affecting-the-gastrointestinal-tract-in-the-setting-of-post-living-donor-kidney-transplantation
#6
Victor H Jimenez-Zepeda, Rajkumar Vajpeyi, Rohan John, Suzanne Trudel
Light chain deposition disease (LCDD) is an uncommon, clonal plasma cell proliferative disorder, in which monoclonal immunoglobulin light chains deposit in various tissues, resulting in organ dysfunction. Gastrointestinal (GI) involvement has been described in both primary and secondary amyloidosis, but has rarely been reported in LCDD, and only as an incidental finding. We report a case of LCDD in living related kidney transplant recipient presenting with severe GI dysmotility, weight loss and progressive allograft dysfunction...
July 2012: International Journal of Hematology
https://www.readbyqxmd.com/read/21705817/the-candidate-for-renal-transplantation-work-up-medical-urological-and-oncological-evaluation
#7
REVIEW
R Cabello Benavente, C Quicios Dorado, L López Martin, C Simón Rodríguez, P Charry Gónima, C González Enguita
UNLABELLED: Renal transplantation prolongs life, reduces morbidity, improves quality of life, and enables social rehabilitation of patients with end stage renal disease (ESRD). Kidney transplantation is a surgical procedure with inherent risks due to anesthesia and the surgical procedure itself. In ESRD patients medical background and comorbidities are crucial at the time of considering a renal transplant candidate because they can determine the procedure success OBJECTIVES: To update and review, according to recent literature, the evaluation of renal transplant candidates...
June 2011: Archivos Españoles de Urología
https://www.readbyqxmd.com/read/20557477/liver-transplantation-in-children-with-metabolic-diseases-the-studies-of-pediatric-liver-transplantation-experience
#8
Ronen Arnon, Nanda Kerkar, Michael K Davis, Ravinder Anand, Wanrong Yin, Regino P González-Peralta
Metabolic diseases are the second largest indication for LT in children after BA. There are limited data on the long-term post-transplant outcome in this unique group of patients. Therefore, our aim was to assess post-liver transplant outcomes and to evaluate risk factors for mortality and graft loss in children with metabolic disorders in comparison to those with non-metabolic diagnoses. We reviewed all patients enrolled in the SPLIT registry. Between 1995 and 2008, 446 of 2997 (14.9%) children enrolled in SPLIT underwent liver transplant for metabolic diseases...
September 1, 2010: Pediatric Transplantation
https://www.readbyqxmd.com/read/20025984/the-role-of-anaerobic-bacteria-in-bacteremia
#9
REVIEW
Itzhak Brook
Anaerobic bacteria remain an important cause of bloodstream infections and account for 1-17% of positive blood cultures. This review summarizes the epidemiology, microbiology, predisposing conditions, and treatment of anaerobic bacteremia (AB) in newborns, children, adults and in patients undergoing dental procedures. The majority of AB are due to Gram-negative bacilli, mostly Bacteroides fragilis group. The other species causing AB include Peptostreptococcus, Clostridium spp., and Fusobacterium spp. Many of these infections are polymicrobial...
June 2010: Anaerobe
https://www.readbyqxmd.com/read/19918163/aggressive-posttransplant-lymphoproliferative-disease-in-a-renal-transplant-patient-treated-with-alemtuzumab
#10
Mahvish Muzaffar, Asma Taj, Shobha Ratnam
Post transplant lymphoproliferative disease (PTLD) is a rare but potentially fatal complication after solid organ transplantation. The risk of PTLD varies with type of organ transplant, Epstein-Barr virus serostatus of the donor and recipient, age, and intensity of immunosuppression. We report a case of a 45-year-old man who developed aggressive PTLD 7 months after receiving a cadaveric renal transplant. He received 30 mg alemtuzumab intravenously intraoperatively as induction immunosuppression followed by maintenance immunosuppression with tacrolimus and mycophenolate mofetil...
November 2010: American Journal of Therapeutics
https://www.readbyqxmd.com/read/18412811/late-onset-epstein-barr-virus-negative-post-transplant-lymphoproliferative-disorder-presenting-as-ulcerated-necrotic-papules-and-nodules-in-a-renal-transplant-patient
#11
Mark B Y Tang, Eugene S T Tan, Suat Hoon Tan
We report a case of B-cell post-transplant lymphoproliferative disorder in a 57-year-old female 19 years postrenal transplant patient who presented with multiple, progressive, painful ulcerated necrotic papules and nodules over the left leg. Histopathological examination showed diffuse infiltration of the dermis by large atypical B-lymphoid cells, with a negative in situ hybridization test for Epstein-Barr virus. Gastrointestinal involvement was evident by the presence of atypical lymphoid cells in the peritoneal fluid...
May 2008: Australasian Journal of Dermatology
https://www.readbyqxmd.com/read/16967795/rectal-malakoplakia-presenting-as-a-mass-and-fistulous-tract-in-a-renal-transplant-patient
#12
Muhammad Yousif, Zaigham Abbas, Muhammad Mubarak
Malakoplakia (MK) is a rare, chronic inflammatory disorder with characteristic morphologic features. It most commonly involves urogenital organs but can affect any organ system in the body. Gastrointestinal tract is the second common site of involvement. It commonly occurs in nontransplant patients but transplant patients are also vulnerable to it. We present a case report of a forty year old male renal transplant patient, who received a kidney from his brother with 1 haplotype and 4 antigen match. He was on regular post transplant follow up with stable graft function...
August 2006: JPMA. the Journal of the Pakistan Medical Association
https://www.readbyqxmd.com/read/16046517/questionnaire-based-evaluation-of-gastrointestinal-disorders-in-de-novo-renal-transplant-patients-receiving-either-mycophenolate-mofetil-or-enteric-coated-mycophenolate-sodium
#13
COMPARATIVE STUDY
Nassim Kamar, Loubna Oufroukhi, Patrick Faure, David Ribes, Olivier Cointault, Laurence Lavayssiere, Marie Béatrice Nogier, Laure Esposito, Dominique Durand, Lionel Rostaing
BACKGROUND: Gastrointestinal (GI) disorders are one of the main adverse events in patients treated by mycophenolic acid (MPA). The aim of our prospective questionnaire-based study was to assess GI side-effects in de novo renal-transplant patients receiving either mycophenolate mofetil (MMF) or enteric-coated mycophenolate sodium (EC-MPS). METHODS: Between January 2002 and April 2003, all patients receiving MPA with a functioning allograft at 1 month post-transplantation were enrolled in this study (n = 130)...
October 2005: Nephrology, Dialysis, Transplantation
https://www.readbyqxmd.com/read/15717118/epstein-barr-virus-associated-lymphoproliferative-disorder-presenting-as-apparently-isolated-gastrointestinal-lesions-in-childhood
#14
N J Sebire, M Malone, R A Risdon, A D Ramsay
We present an unusual case of post-transplant lymphoproliferative disorder (PTLD) presenting as apparently isolated gastrointestinal lesions in a pediatric renal transplant recipient. The multiple bowel lesions were related to Epstein-Barr virus and demonstrated the appearance of a monomorphic PTLD that was morphologically indistinguishable from diffuse large B-cell lymphoma. The patient responded to therapy with targeted anti-CD20 immunotherapy. PTLD may manifest as apparently isolated gastrointestinal tract lesions in childhood...
January 2005: Pediatric and Developmental Pathology
https://www.readbyqxmd.com/read/12709080/renal-transplant-recipient-attitudes-toward-steroid-use-and-steroid-withdrawal
#15
G V Ramesh Prasad, Michelle M Nash, Philip A McFarlane, Jeffrey S Zaltzman
Although steroid avoidance and withdrawal in renal transplant recipients (RTR) are actively being evaluated by physicians, the attitudes of recipients toward steroid use have not been systematically studied in the modern era. We conducted a confidential written survey of single-organ adult RTR pertaining to prednisone-related side-effects. Recipients were asked which drug they felt maximized graft life, which drug they wished to avoid if graft life was unaffected, and which drug they had most compliant with...
April 2003: Clinical Transplantation
https://www.readbyqxmd.com/read/11669498/epstein-barr-virus-associated-t-cell-lymphoma-in-solid-organ-transplant-recipients
#16
REVIEW
P Sivaraman, W C Lye
Post-transplantation lymphoproliferative diseases (PTLDs) are a heterogenous group of lymphoid proliferative disorders occurring in transplant patients. Most PTLDs are B-cell in origin; T-cell PTLDs are seldom reported, and EBV-associated T-cell PTLDs are rare. The first case of a T-cell, non-EBV-associated PTLD was first described in a renal allograft recipient in 1987. A total of 40 cases of T-cell PTLDs in solid organ transplant recipients have been reported. However, so far only 16 cases of EBV-associated T-cell PTLDs have been reported in the literature...
September 2001: Biomedicine & Pharmacotherapy, Biomédecine & Pharmacothérapie
https://www.readbyqxmd.com/read/11213063/use-of-mycophenolate-mofetil-as-rescue-therapy-after-pediatric-liver-transplantation
#17
C Chardot, J E Nicoluzzi, M Janssen, E Sokal, J Lerut, J B Otte, R Reding
BACKGROUND: Mycophenolate mofetil (MMF) has been increasingly used after liver transplantation (LT) in adults. We report our preliminary experience with MMF as rescue therapy after pediatric LT. METHODS: A total of 19 children received MMF for 21 indications. Median age at LT was 30 months (range 7-149). The median initial oral dose of MMF was 23 mg/kg/day (range 12-43) orally. Median follow-up after initiation of MMF therapy was 642 days (range 229-1606). RESULTS: 1) EFFICACY: MMF was indicated for rejection or insufficient immunosuppression in 16 cases, with normalization of both liver function tests and liver histology in 10 (62%)...
January 27, 2001: Transplantation
https://www.readbyqxmd.com/read/11185538/early-gastric-post-transplantation-lymphoproliferative-disorder-and-h-pylori-detection-after-kidney-transplantation-a-case-report-and-review-of-the-literature
#18
REVIEW
C L Nash, L M Price, D A Stewart, F Sepandj, S Yilmaz, A Barama
The incidence of post-transplantation lymphoproliferative disorder (PTLD) in the adult renal transplant population ranges from 0.7% to 4%. The majority of cases involve a single site and arise, on average, seven months after transplantation. Histopathology usually reveals B-cell proliferative disease and has been standardized into its own classification. Treatment modalities consist of decreased immunosuppression, eradication of Epstein-Barr virus, surgical resection, systemic chemotherapy and monoclonal antibody therapy; however, mortality remains high, typically with a short survival time...
September 2000: Canadian Journal of Gastroenterology, Journal Canadien de Gastroenterologie
https://www.readbyqxmd.com/read/9504692/post-transplantation-lymphoproliferative-disorders-in-mexico-an-aggressive-clonal-disease-associated-with-epstein-barr-virus-type-a
#19
COMPARATIVE STUDY
L Quintanilla-Martínez, C Lome-Maldonado, F Schwarzmann, E Gredler, E Reyes, A Angeles-Angeles, F Fend
Post-transplantation lymphoproliferative disorders (PT-LPDs) are a complication of immunosuppression with variable clinical behavior and frequent Epstein-Barr virus (EBV) association. There is geographic variation in the association of EBV with certain tumors and a lack of studies of PT-LPDs from developing countries, so we decided to study in detail a series of PT-LPDs from Mexico to identify similarities and differences between populations in Mexico and those in Europe and the United States. We used paraffin-embedded tissue from eight PT-LPDs (six from men, two from women) that arose after renal transplantation...
February 1998: Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc
https://www.readbyqxmd.com/read/7977315/magnesium-deficiency-pathophysiologic-and-clinical-overview
#20
REVIEW
S M al-Ghamdi, E C Cameron, R A Sutton
Magnesium is an essential cation, involved in many enzymatic reactions, as a cofactor to adenosine triphosphatases. It is critical in energy-requiring metabolic processes, as well as protein synthesis and anaerobic phosphorylation. Serum Mg concentration is maintained within a narrow range by the kidney and small intestine since under conditions of Mg deprivation both organs increase their fractional absorption of Mg. If Mg depletion continues, the bone store contributes by exchanging part of its content with extracellular fluid (ECF)...
November 1994: American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation
keyword
keyword
64548
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"